ANI Pharmaceuticals
ANIP
ANIP
126 hedge funds and large institutions have $391M invested in ANI Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 46 increasing their positions, 33 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more funds holding
Funds holding: 126 → 126 (0)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.18% less ownership
Funds ownership: 58.92% → 58.74% (-0.18%)
Holders
126
Holding in Top 10
2
Calls
$905K
Puts
$688K
Top Buyers
| 1 | +$3.58M | |
| 2 | +$2.35M | |
| 3 | +$1.76M | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$1.6M |
| 5 |
RCAMU
Rothschild & Co Asset Management US
Stamford,
Connecticut
|
+$1.4M |
Top Sellers
| 1 | -$4.47M | |
| 2 | -$3.21M | |
| 3 | -$1.29M | |
| 4 |
LSV Asset Management
Chicago,
Illinois
|
-$1.14M |
| 5 |
JCIA
Jackson Creek Investment Advisors
Castle Rock,
Colorado
|
-$1.03M |